Mycophenolic Acid Tablet, Delayed Release
Product Images NDC 67877-929

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Mycophenolic Acid (NDC 67877-929). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mycophenolicacid-180mg-100tab-cart-a (Mycophenolicacid 180mg 100tab Cart A)

This is a product description for Mycophenolic Acid Delayed-Release Tablets, USP by ASCEND. The packaging includes 100 unit-dose tablets containing 180 mg of mycophenolic acid each. The tablets are not child-resistant and should be kept out of reach of children. The dosage information is provided in the package insert, and it is recommended to store the tablets in a tight container at a temperature between 20°C to 25°C (68°F to 77°F). The tablets are distributed by Ascend Laboratories, LLC.*

FDA Label Image

Mycophenolicacid-180mg-120tab-b (Mycophenolicacid 180mg 120tab B)

FDA Label Image

Mycophenolicacid-180mg-500tab (Mycophenolicacid 180mg 500tab)

This text provides information about delayed-release tablets containing 180 mg of mycophenolic acid (as mycophenolate sodium, USP). It includes dosage instructions, storage conditions, manufacturer details, distributor information, and a reminder to dispense the accompanying Medication Guide to each patient. Additionally, the text mentions to protect from moisture and to dispense in a tight container. The tablets are identified as having a white, unvarnished area measuring 45 x 30 mm with rest labeling done with UV varnish. The tablets are distributed by Ascend Laboratories, LLC and manufactured by Alkem Laboratories Ltd.*

FDA Label Image

Mycophenolicacid-360mg-100tab-cart-a (Mycophenolicacid 360mg 100tab Cart A)

This text is a label for Mycophenolic Acid Delayed-Release Tablets, USP. The label provides information on dosage, storage instructions, and safety precautions. It also indicates that a Medication Guide should be dispensed to each patient. The tablets contain 360 mg of mycophenolic acid per tablet and are not child-resistant. The manufacturer is Alkem Laboratories Ltd., based in Mumbai, India, and the tablets are distributed by Ascend Laboratories, LLC in Bedminster, NJ.*

FDA Label Image

Mycophenolicacid-360mg-120tab-b (Mycophenolicacid 360mg 120tab B)

The text describes delayed-release tablets containing 360 mg of mycophenolic acid, as mycophenolate sodium, USP. It provides instructions for dosage, storage conditions, and cautions for keeping drugs away from children. The tablets are manufactured by Alkem Laboratories Ltd. in Mumbai, India, and distributed by Ascend Laboratories, LLC in Bedminster, NJ. The packaging includes a Medication Guide for each patient. The product should be dispensed in a tight container and protected from moisture.*

FDA Label Image

Mycophenolicacid-360mg-500tab (Mycophenolicacid 360mg 500tab)

This text provides information on delayed-release tablets containing 360 mg of mycophenolic acid. The dosage instructions are indicated in the package insert. It is advised to protect the tablets from moisture and store them in a tight container at a temperature range of 20°C to 25°C (68°F to 77°F). The tablets are manufactured by Alkem Laboratories Ltd. in India and distributed by Ascend Laboratories, LLC in Bedminster, NJ. The tablets should be dispensed with a Medication Guide to patients. The text also includes manufacturing details and a code number for identification.*

FDA Label Image

Myco-str (Mycophenolicacid Str 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.